Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Fillerâ„¢
Biosenta announces a pivotal discovery revealed that Tri-Fillerâ„¢ effectively sterilizes a wide range of microorganisms.
top of page
News
Search
- Sep 6
- 4 min
Biosenta builds on partnership with AMPAK to test and commercialize Tri-Fillerâ„¢
Biosenta will test Tri-Fillerâ„¢ in plastics at AMPAK Inc. facilities with an eye to commercialization.
22 views
- Aug 8
- 5 min
Biosenta announces further advances in research and development of Tri-Fillerâ„¢
Biosenta Inc. announces further advances in research and development of the Tri-Fillerâ„¢ particle.
68 views
- Jul 17
- 2 min
Biosenta announces termination of joint venture and issuance of securities
Biosenta has completed termination of its joint venture agreement between the Company and 19443391 Ontario Inc and issued common shares.
45 views
- Jun 23
- 7 min
Biosenta announces entering into of agreement to terminate joint venture
Biosenta announces entering into of agreement to terminate joint venture
48 views
- May 31
- 1 min
Biosenta Inc. ceases negotiations with Voran Group Ventures Ltd.
Biosenta Inc. announces that it has ceased negotiations with Voran Group Ventures Ltd.
35 views
- Oct 17, 2022
- 3 min
Biosenta Inc. enters into an MOU with Voran Group Ventures Ltd.
Biosenta Inc. has signed an MOU with Voran Group Ventures Ltd. for the commercialization of Biosenta’s Tri-Filler® antimicrobial products.
70 views
- Jul 13, 2022
- 1 min
Biosenta Annual Meeting 2022
Biosenta Inc. announced the annual general meeting of shareholders will take place on Tuesday, August 16, 2022, at 11:00am Eastern Time.
49 views
- May 26, 2022
- 3 min
University of Calgary very encouraging anti-bacterial Biosenta particles for construction industry
University of Calgary very encouraging anti-bacterial Biosenta particles for construction industry
44 views
- Mar 28, 2022
- 5 min
Biosenta Announces Shares for Debt Settlement
Biosenta Inc. announces that it has entered into an agreement to settle $1,015,088.47 of debt through issuance of 3,625,315 common shares.
65 views
- May 5, 2021
- 2 min
Biosenta Announces Stock Option Grant
Biosenta has granted an aggregate of 1,017,000 stock options.
131 views
- Mar 1, 2021
- 2 min
Biosenta Announces Stock Option Grant
Biosenta announces that it has granted to certain directors, officers, employees and consultants of the Company 350,000 stock options.
116 views
- Jan 28, 2021
- 3 min
01/28/2021 - Biosenta Announces Note Financing
Biosenta will enter into a series of prime plus 5% unsecured promissory notes in consideration for cash investments in the amount of $85,000
111 views
- Jan 26, 2021
- 1 min
01/26/2021 - Biosenta Announces Record Revenues
Today, Biosenta realized its first purchase order and payment from the supply and purchase agreement with SANITIZATION 360.
158 views
- Dec 22, 2020
- 1 min
12/22/2020 - U.S. Partner Secures Licensing Rights
On December 21, 2020 Biosenta’s U.S. licensing partner Kleen Bee Labs, LLC has secured licensing rights in Ralphs and Food 4 Less retailers.
138 views
- Dec 18, 2020
- 1 min
12/18/2020 - Unaware of Any Material Change
Biosenta confirms that the management is unaware of any material change that would account for the recent increase in market activity.
81 views
- Dec 17, 2020
- 1 min
12/17/2020 - Biosenta growth milestone
Biosenta’s stock closed at 0.75 CAD +0.37 (97.37%). This is in step with Biosenta’s strategic business plan grow the company.
97 views
- Sep 24, 2020
- 3 min
09/24/2020 - Biosenta and University of Calgary enter into a four year partnership
This partnership enables the University team to research nanoparticles for use as antimicrobial filler in commercial construction materials.
112 views
- Sep 14, 2020
- 2 min
09/14/2020 - Biosenta Announces Royalty License Agreement for North American Distribution
A strategic licensing partnership with Kleen Bee Labs was finalized today. This license will give the rights for distribution of DualXtiv.
121 views
- Sep 9, 2020
- 2 min
09/09/2020 - Biosenta Announces launching trueâ„¢ in North America
Biosenta is launching a dual-action, broad-spectrum anti-microbial disinfectant to combat COVID-19 in North America.
98 views
bottom of page